Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,currency,priceHint,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,exchange,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jul 14, 2021) 4","Short Ratio (Jul 14, 2021) 4","Short % of Float (Jul 14, 2021) 4","Short % of Shares Outstanding (Jul 14, 2021) 4","Shares Short (prior month Jun 14, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry,address2
t0,IRTC,308710000.0,29303000,8510000,,-27681000,,-27779000,69813000,50853000,-27470000,-27470000,,-335000,,,,98000,74311000,101781000,23458000,-211000,,-27779000,-27779000,641996000.0,168915000.0,309572000.0,4984000.0,478487000.0,27000.0,-332463000.0,1836000.0,862000.0,12000.0,14866000.0,137375000.0,59382000.0,11667000.0,12000.0,126653000.0,336106000.0,124911000.0,59982000.0,18427000.0,6863000.0,5152000.0,121246000,1168000,117035000,-2917000,-26446000,-7892000,1576000,48747000,-25105000,-41842000,3591000,-1608000,-39818000,30496000,-4211000,276724000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,0.3765697,47.3332 - 48.46,47.8,0.0,0.0,10,14,finmb_34159879,NasdaqGS,"iRhythm Technologies, Inc.",USD,494946,195300,6.3240013,0.15181491,41.656 - 286.19,-238.21,-0.8323492,41.656,286.19,1620331200,1635937140,1636372800,-1.579,-2.05,USD,2,-3.57,-13.439776,11.772,48.77257,-0.792572,-0.016250364,85.763115,-37.783115,-0.44055206,1405957888,-23.404879,4.075773,15,America/New_York,EDT,-14400000,NMS,0,False,False,47.98,1630526403,0.1800003,48.0,48.46,47.3332,283304,"iRhythm Technologies, Inc.",us_market,PRE,1.45,,,286.19,41.66,48.77,85.76,494.95k,195.3k,29.3M,,28.93M,1.34%,100.54%,2.15M,4.14,9.14%,7.34%,1.81M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-22.67%,-22.46%,-10.17%,-28.79%,275.94M,9.74,17.00%,194.89M,-54.59M,-62.54M,-1.58,,262.29M,8.95,124.24M,40.13,5.66,11.77,-33.23M,-13.35M,Value,94103,Healthcare,1157,8,9,"iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.",San Francisco,415 632 5700,CA,7,1609372800,1625097600,8,United States,http://www.irhythmtech.com,86400,8,699 8th Street,Medical Instruments & Supplies,Suite 600
t-1,IRTC,340750000.0,29303000,11604000,,-9675000,,-9651000,56288000,58311000,-9581000,-9581000,,-374000,,,,-24000,78809000,88390000,20498000,-94000,,-9651000,-9651000,646258000.0,170127000.0,341612000.0,5687000.0,511739000.0,27000.0,-304684000.0,1830000.0,862000.0,11000.0,14091000.0,88628000.0,65665000.0,11667000.0,11000.0,118961000.0,377825000.0,246589000.0,29932000.0,21339000.0,5313000.0,4365000.0,-15121000,811000,-17485000,-1944000,2959000,-2000,6200000,-6708000,-1297000,7818000,-2519000,-330000,-11957000,31466000,-2364000,312160000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,0.3765697,47.3332 - 48.46,47.8,0.0,0.0,10,14,finmb_34159879,NasdaqGS,"iRhythm Technologies, Inc.",USD,494946,195300,6.3240013,0.15181491,41.656 - 286.19,-238.21,-0.8323492,41.656,286.19,1620331200,1635937140,1636372800,-1.579,-2.05,USD,2,-3.57,-13.439776,11.772,48.77257,-0.792572,-0.016250364,85.763115,-37.783115,-0.44055206,1405957888,-23.404879,4.075773,15,America/New_York,EDT,-14400000,NMS,0,False,False,47.98,1630526403,0.1800003,48.0,48.46,47.3332,283304,"iRhythm Technologies, Inc.",us_market,PRE,1.45,,,286.19,41.66,48.77,85.76,494.95k,195.3k,29.3M,,28.93M,1.34%,100.54%,2.15M,4.14,9.14%,7.34%,1.81M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-22.67%,-22.46%,-10.17%,-28.79%,275.94M,9.74,17.00%,194.89M,-54.59M,-62.54M,-1.58,,262.29M,8.95,124.24M,40.13,5.66,11.77,-33.23M,-13.35M,Value,94103,Healthcare,1157,8,9,"iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.",San Francisco,415 632 5700,CA,7,1609372800,1625097600,8,United States,http://www.irhythmtech.com,86400,8,699 8th Street,Medical Instruments & Supplies,Suite 600
t-2,IRTC,333684000.0,29303000,8768000,,-4572000,,-4677000,49701000,53712000,-4757000,-4757000,,-384000,,,,105000,71944000,76701000,18232000,185000,,-4677000,-4677000,629484000.0,162655000.0,334546000.0,5024000.0,497201000.0,27000.0,-295033000.0,,862000.0,68000.0,11378000.0,95336000.0,55866000.0,10694000.0,68000.0,119022000.0,365939000.0,231901000.0,28955000.0,24252000.0,5062000.0,3838000.0,-198880000,-419000,-204481000,-1944000,207145000,1466000,210708000,13606000,-3563000,10942000,3213000,-44000,-13006000,24409000,-5601000,310073000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,0.3765697,47.3332 - 48.46,47.8,0.0,0.0,10,14,finmb_34159879,NasdaqGS,"iRhythm Technologies, Inc.",USD,494946,195300,6.3240013,0.15181491,41.656 - 286.19,-238.21,-0.8323492,41.656,286.19,1620331200,1635937140,1636372800,-1.579,-2.05,USD,2,-3.57,-13.439776,11.772,48.77257,-0.792572,-0.016250364,85.763115,-37.783115,-0.44055206,1405957888,-23.404879,4.075773,15,America/New_York,EDT,-14400000,NMS,0,False,False,47.98,1630526403,0.1800003,48.0,48.46,47.3332,283304,"iRhythm Technologies, Inc.",us_market,PRE,1.45,,,286.19,41.66,48.77,85.76,494.95k,195.3k,29.3M,,28.93M,1.34%,100.54%,2.15M,4.14,9.14%,7.34%,1.81M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-22.67%,-22.46%,-10.17%,-28.79%,275.94M,9.74,17.00%,194.89M,-54.59M,-62.54M,-1.58,,262.29M,8.95,124.24M,40.13,5.66,11.77,-33.23M,-13.35M,Value,94103,Healthcare,1157,8,9,"iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.",San Francisco,415 632 5700,CA,7,1609372800,1625097600,8,United States,http://www.irhythmtech.com,86400,8,699 8th Street,Medical Instruments & Supplies,Suite 600
t-3,IRTC,117084000.0,29303000,12542000,,-20306000,,-20437000,43014000,35394000,-20162000,-20162000,,-381000,,,,131000,50878000,71040000,15484000,-144000,,-20437000,-20437000,408096000.0,158278000.0,117946000.0,4763000.0,276224000.0,25000.0,-290356000.0,,862000.0,181000.0,10870000.0,81730000.0,47314000.0,7778000.0,181000.0,117957000.0,146535000.0,33196000.0,22877000.0,27164000.0,4989000.0,5012000.0,31845000,-1623000,29664000,-1944000,5705000,-1633000,6392000,25216000,-687000,-10153000,3160000,-824000,-3005000,14213000,-2181000,99221000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,0.3765697,47.3332 - 48.46,47.8,0.0,0.0,10,14,finmb_34159879,NasdaqGS,"iRhythm Technologies, Inc.",USD,494946,195300,6.3240013,0.15181491,41.656 - 286.19,-238.21,-0.8323492,41.656,286.19,1620331200,1635937140,1636372800,-1.579,-2.05,USD,2,-3.57,-13.439776,11.772,48.77257,-0.792572,-0.016250364,85.763115,-37.783115,-0.44055206,1405957888,-23.404879,4.075773,15,America/New_York,EDT,-14400000,NMS,0,False,False,47.98,1630526403,0.1800003,48.0,48.46,47.3332,283304,"iRhythm Technologies, Inc.",us_market,PRE,1.45,,,286.19,41.66,48.77,85.76,494.95k,195.3k,29.3M,,28.93M,1.34%,100.54%,2.15M,4.14,9.14%,7.34%,1.81M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-22.67%,-22.46%,-10.17%,-28.79%,275.94M,9.74,17.00%,194.89M,-54.59M,-62.54M,-1.58,,262.29M,8.95,124.24M,40.13,5.66,11.77,-33.23M,-13.35M,Value,94103,Healthcare,1157,8,9,"iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.",San Francisco,415 632 5700,CA,7,1609372800,1625097600,8,United States,http://www.irhythmtech.com,86400,8,699 8th Street,Medical Instruments & Supplies,Suite 600
